In addition, reducing YTHDF2 reduced m6A-containing IL11 and SERPINE2 mRNA in hepatocellular carcinoma to aggravate inflammation and vascular abnormalities (Hou et al., 2019). Here, YTHDF2 is linked to hepatocellular carcinoma.